Gaoxing Zhang - Publications

Sirolimus-coated versus paclitaxel-coated balloons for bifurcated coronary lesions in the side branch: the SPACIOUS trial.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Published: March 17, 2025

Association between relative fat mass and cardiovascular disease: a cross sectional study based on NHANES.

Journal: Frontiers in cardiovascular medicine

Published: March 10, 2025

Efficacy and safety of clevidipine emulsion injection compared with nicardipine in patients with hypertensive emergencies: a randomized, single-blind, positive-parallel-controlled, phase III clinical trial.

Journal: Journal of hypertension

Published: August 14, 2024

Effectiveness of sodium-glucose co-transporter 2 inhibitors on atrial fibrillation recurrence after catheter ablation: A systemic review and meta-analysis.

Journal: International journal of cardiology

Published: June 04, 2024

The traditional Chinese medicine Qiliqiangxin in heart failure with reduced ejection fraction: a randomized, double-blind, placebo-controlled trial.

Journal: Nature medicine

Published: November 28, 2023

Relationship between Coronary Artery Calcium Score and Coronary Stenosis.

Journal: Cardiology research and practice

Published: April 25, 2023

Appraisal of guidelines for managing contrast medium in patients with metformin: consensuses, controversies, and gaps.

Journal: European radiology

Published: September 18, 2022

Characteristics of Patent Foramen Ovale: Analysis from a Single Center.

Journal: Cardiology research and practice

Published: March 04, 2022

Critical Appraisal of Guidelines for Antithrombotic Therapy in Atrial Fibrillation Post-Percutaneous Coronary Intervention.

Journal: Global heart

Published: January 04, 2022

MiR-126-HMGB1-HIF-1 Axis Regulates Endothelial Cell Inflammation during Exposure to Hypoxia-Acidosis.

Journal: Disease markers

Published: October 02, 2021

Circulating senescent angiogenic T cells are linked with endothelial dysfunction and systemic inflammation in hypertension.

Journal: Journal of hypertension

Published: November 16, 2020

Allisartan Isoproxil Improves Endothelial Function and Vascular Damage in Patients with Essential Hypertension: A Single-Center, Open-Label, Randomized Controlled Trial.

Journal: Advances in therapy

Published: April 26, 2020